Has Etienne Poufong received payments from drug or device companies?

Yes. Drug and device makers reported $3,756 in general payments to Etienne Poufong across 105 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Etienne Poufong did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Etienne Poufong come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Etienne Poufong

Psychiatric/Mental Health · Arlington, TXNPI 1023626959

Payments from drug & device makers

$3,756in general payments, 2019–2025

Across 105 payments — averaging $35.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$2K
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$544
AbbVie$356
Alkermes, Inc.$295
Neurocrine Biosciences, Inc.$94
Axsome Therapeutics, Inc.$91
plus $360 from 12 others

What the payments were for

Food & beverage$3,756100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	33	$2,016
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	20	$544
AbbVie	13	$356
Alkermes, Inc.	13	$295
Neurocrine Biosciences, Inc.	3	$94
Axsome Therapeutics, Inc.	4	$91
Otsuka America Pharmaceutical, Inc.	4	$69
E.r. Squibb & Sons, L.L.C.	2	$46
Sunovion Pharmaceuticals Inc.	2	$36
Orexo US, Inc.	2	$34
Takeda Pharmaceuticals U.S.A., Inc.	2	$31
Jazz Pharmaceuticals Inc.	1	$25
Adlon Therapeutics L.p.	1	$24
Almatica Pharma LLC	1	$23
Teva Pharmaceuticals USA, Inc.	1	$21
Lundbeck LLC	1	$19
Supernus Pharmaceuticals, Inc.	1	$18
Collegium Pharmaceutical, Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,756 in reported general payments places this provider in the 85th percentile of 2,724 psychiatric/mental health providers in Texas.

See all psychiatric/mental health providers in Texas →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
IngrezzaValbenazine Tosylate	19	$138,732
LatudaLurasidone Hcl	16	$35,901
VraylarCariprazine Hcl	17	$27,559
Aripiprazole	59	$3,955
Quetiapine Fumarate	51	$2,548
Trazodone Hcl	111	$2,533
Bupropion XlBupropion Hcl	54	$1,877
Vilazodone Hcl	13	$1,616
Hydroxyzine Hcl	32	$1,348
Clozapine	25	$1,269
Duloxetine Hcl	47	$1,240
Buspirone Hcl	66	$1,211
Risperidone	30	$1,158
Fluvoxamine Maleate	18	$1,003
Alprazolam	208	$985

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Neurocrine Biosciences, Inc.Ingrezza	$94	$138,73219 claims
Sunovion Pharmaceuticals Inc.Latuda	$36	$35,90116 claims
AbbVieVraylar	$356	$27,55917 claims
Almatica Pharma LLCSertraline Hcl	$23	$27021 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,724 psychiatric/mental health providers in Texas.

Other psychiatric/mental health in Arlington

Fredrick OdongoArlington$39K
Christiana OmamegbeArlington$14K
Tracy HicksLongview$684K
Natalie TellezHouston$602K
Karah BrashierRichardson$567K
Grant DavisRichardson$360K
Victor IlogEl Paso$167K
Lisa ShamblinGrapevine$163K
Monique GonzalezSan Antonio$126K
Marguerite AddisonWaco$118K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →